Login
$VOR
$18.83 -$0.14 (0.74%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Jean-Paul Kress Also a director
President, Chief Executive Officer and Chairman
60 Not stated $65,027,569
Sandesh Mahatme
Chief Financial Officer
61 Since 2025
1 year
$39,406,098
Jeremy Sokolove
Chief Medical Officer
52 Since 2025
1 year
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 27, 2026 · updated by the 8-K of Jul 7, 2026

Directors
8
serving now
Independent
6 of 7
stated in the proxy; 1 not stated
Average tenure
1.9 years
from year joined
CEO also chairs the board
Yes
Jean-Paul Kress
Director Age On board Independent Committees Other public boards 2025 pay Source
Jean-Paul Kress
60 2025
1 year
Not independent None stated None stated Paid as CEO
Daniella Beckman
47 2020
6 years
Independent
Audit · Chair Compensation
Upstream Bio $64,200
Fouad Namouni
57 2024
2 years
Independent
Compensation Nominating and Corporate Governance · Chair
None stated $51,089
Erez Kalir
54 2025
1 year
Independent
Audit
None stated $123,033
Wouter Joustra
37 2025
1 year
Not stated None stated NewAmsterdam Pharma N.V. $31,881
Alexander (Bo) Cumbo
55 2025
1 year
Independent
Compensation · Chair Nominating and Corporate Governance
None stated $121,365
Michel Detheux
59 2025
1 year
Independent
Audit
None stated $119,350
David Zaccardelli Joined Jul 7, 2026
- - Independent - - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 27, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support